More from Dr Oliver Hartwich for all those who haven’t had enough bad news on the EUR.
More from Dr Oliver Hartwich for all those who haven’t had enough bad news on the EUR.
Most Popular
Sponsored
BRZE's 20% revenue growth & 2.5x P/S valuation shine; STBA & COLB lag on growth.
AVGO's 90% 2025 gain is priced in. Expensive at 86x trailing earnings, but AI chips offer future growth.
Banks gain 10.2% but WSBC, TRMK, FFBC face risks: low NIM, slow EPS growth, high P/B.
ARMK beats revenue estimates with 14.7% growth; new AI data center deals boost future outlook.
US funds boost SMR nuclear stocks! Billions for plants signal growth, but watch regulatory hurdles.
GEO Group beats Q1 estimates with 16.6% revenue growth & improved margins. Valuation metrics hint at upside.
SE beats Q1 estimates with 42.8% revenue growth & $0.81 EPS. AI & logistics drive gains.
Sponsored
Must Read